Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell
• CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Preview: Fulcrum Therapeutics’s Earnings
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Tuesday, 2023-11-07. Here’s what investors…
Benzinga’s Top Ratings Upgrades, Downgrades For September 25, 2023
Upgrades For Steel Dynamics Inc (NASDAQ:STLD), Citigroup upgraded the previous rating of Neutral to Buy. For the second…
The Latest Analyst Ratings for Fulcrum Therapeutics
Fulcrum Therapeutics (NASDAQ:FULC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847.
Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program
Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of
Benzinga’s Top Ratings Upgrades, Downgrades For August 23, 2023
Upgrades For Beazer Homes USA Inc (NYSE:BZH), Sidoti & Co. upgraded the previous rating of Neutral to Buy.…
Crude Oil Falls; Dick’s Sporting Goods Earnings Miss Views
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday.
The Dow traded down 0.39% to 34,330.87 while the NASDAQ rose 0.24% to 13,530.50. The S&P 500, also fell, dropping, 0.11% to 4,394.78.
Why Macy’s Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Fulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday’s regular session. Fulcrum Therapeutics’s stock is trading…